FDA Approves New Workflow Option for Roche's Cobas HPV Test | GenomeWeb

NEW YORK (GenomeWeb News) – Roche today said that the US Food and Drug Administration approved a new workflow process for the company's Cobas HPV test.

The newly approved workflow option allows for a sample to be processed from the primary sample collection vial directly after it has been used for cytology testing. This allows laboratories to load the same vial used for a ThinPrep Pap test onto the Cobas 4800 system for high-risk human papillomavirus and individual HPV 16 and HPV 18 genotype testing, Roche said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Mar
09
Sponsored by
Bio-Rad

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.